Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

"CONFLICT OF INTEREST A patent application was filed by the institutional technology transfer office Inven2 covering SARS‐CoV‐2 epitopes (Inventors: Johanna Olweus, Fridtjof Lund‐Johansen, Saskia Meyer, Isaac Blaas, Even Holth Rustad). All other co‐authors confirm no competing interest."

"Conceptualisation: Saskia Meyer, Isaac Blaas, Johanna Olweus, Arne Kolstad. Methodology: Saskia Meyer, Isaac Blaas, Fridtjof Lund‐Johansen, Johanna Olweus, Arne Kolstad. Resources: Saskia Meyer, Marina Delic‐Sarac, Lise Nissen‐Meyer, Arne Kolstad, Jon Riise, Marton König, Gro Nygaard. Investigation: Saskia Meyer, Isaac Blaas, Trung T. Tran, Ke‐Zheng Dai, John Torgils Vaage, Fridtjof Lund‐Johansen, Johanna Olweus, Malu Lian Hestdalen, Ellen Brodin, Even Holth Rustad, Fredrik Sund, Karin F. Wader, Anne T. Bjornevik, Peter A. Meyer, Arne Kolstad, Jon Riise, Adity Chopra. Formal analysis: Saskia Meyer, Even Holth Rustad, Jon Riise, Arne Kolstad. Visualisation: Saskia Meyer, Even Holth Rustad, Jon Riise, Arne Kolstad. Funding acquisition: Fridtjof Lund‐Johansen, Johanna Olweus, Arne Kolstad, Sigbjørn Smeland. Supervision: Johanna Olweus, Arne Kolstad. Writing – original draft: Saskia Meyer, Even Holth Rustad, Fridtjof Lund‐Johansen, Johanna Olweus, Arne Kolstad, Jon Riise. Writing – review and editing: Johanna Olweus, Saskia Meyer, Even Holth Rustad, Arne Kolstad, Jon Riise, Sigbjørn Smeland."